Publications
227
Citations
30,637
Est. group size
—
Recurring co-author estimate
Active years
36
Publishing since 1991
Typically publishes in teams of ~9 · 24% small-team papers (≤3 authors) · across 26 venues
- Sodium-Glucose Cotransporter Inhibition Preserves Apolipoprotein M During Acute Inflammation in Mice and Humans
JACC Advances · 2025
- Historical review: more than two decades understanding the genetic architecture of hemostasis and thrombosis
Journal of Thrombosis and Haemostasis · 2025
- Genome-wide investigation of exogenous female hormones, genetic variation, and venous thromboembolism risk
Journal of Thrombosis and Haemostasis · 2024
- GENETIC DETERMINANTS OF THROMBOSIS.
PubMed · 2024
- The High Mobility Group A1 (HMGA1) Chromatin Regulator Induces Inflammatory Signals and Promotes Atherogenesis in <i>Tet2</i> Mutant Clonal Hematopoiesis
Blood · 2024
- Cardiac pericytes mediate the remodeling response to myocardial infarction
Journal of Clinical Investigation · 2023
- Effect of the P-Selectin Inhibitor Crizanlizumab on Survival Free of Organ Support in Patients Hospitalized for COVID-19: A Randomized Controlled Trial
Circulation · 2023
- LB 01.5 Effect of the P-selectin Inhibitor Crizanlizumab on Survival Free of Organ Support in Patients Hospitalized for COVID-19: A Randomized Controlled Trial
Research and Practice in Thrombosis and Haemostasis · 2023
- Platelet olfactory receptor activation limits platelet reactivity and growth of aortic aneurysms
DOAJ (DOAJ: Directory of Open Access Journals) · 2022
- Markers of endothelial cell activation are associated with the severity of pulmonary disease in COVID-19
PLoS ONE · 2022
- SCALABLE DIGITAL SOLUTIONS TO ADDRESS PATIENT-CENTERED AMBULATORY CARDIOVASCULAR CARE IN THE GREATER ROCHESTER REGION
Journal of the American College of Cardiology · 2022
- Effect of Crizanlizumab, a P-Selectin Inhibitor, in COVID-19
JACC Basic to Translational Science · 2021
- Estrogen activates endothelial exocytosis
Biochemical and Biophysical Research Communications · 2021
- Abstract 11049: Rare Genetic Variants in Individuals with Low ASCVD Risk and Hard Chd or High Coronary Artery Disease: Multi-Ethnic Study of Atherosclerosis
Circulation · 2021
- Inflammation and cardiovascular disease: From mechanisms to therapeutics
American Journal of Preventive Cardiology · 2020
- Circulation×10
- Blood×4
- Arteriosclerosis Thrombosis and Vascular Biology×3
- PLoS ONE×3
- Journal of the American College of Cardiology×3
- Jason A. Scott
Medicine · Purdue University West Lafayette
- Takayuki Hayami
Medicine · University of Michigan
- Yong Xia
Medicine · The Ohio State University
- Narasimham L. Parinandi
Medicine · The Ohio State University
- Richard E. Klabunde
Medicine · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile